阿奇霉素与多西环素治疗女性无并发症直肠和阴道沙眼衣原体感染的有效性:FemCure多中心观察性研究
FemCure前瞻性多中心队列研究纳入416例女性,比较多西环素(100 mg每日两次×7天)与阿奇霉素(1 g单剂)治疗直肠和阴道沙眼衣原体感染的微生物学治愈率。
要点
- 直肠沙眼衣原体感染女性多西环素治愈率显著高于阿奇霉素。
- 阴道沙眼衣原体感染阿奇霉素与多西环素治愈率无显著差异。
- 直肠感染优先选用多西环素7天方案。
核心结论
- 多西环素治疗女性直肠沙眼衣原体感染有效性高且优于阿奇霉素。
研究设计与样本
- FemCure前瞻性多中心队列研究的一部分,分析416例女性,其中319例同时有直肠和阴道感染,22例仅直肠感染,75例仅阴道感染。
- 直肠CT阳性女性接受多西环素100 mg每日两次共7天;阴道阳性且直肠未检测或阴性女性接受阿奇霉素1 g单剂。
- 入组时及4周随访时自采直肠和阴道样本,终点为4周时核酸扩增试验阴性。
临床怎么用
- 女性直肠沙眼衣原体感染应优先选择多西环素100 mg每日两次共7天方案。
- 阴道沙眼衣原体感染可考虑阿奇霉素1 g单剂或多西环素方案。
局限性
- 为观察性研究,非随机对照设计可能引入混杂偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rectal infections with Chlamydia trachomatis (CT) are prevalent in women visiting a sexually transmitted infection outpatient clinic, but it remains unclear what the most effective treatment is. We assessed the effectiveness of doxycycline and azithromycin for the treatment of rectal and vaginal chlamydia in women. METHODS: This study is part of a prospective multicenter cohort study (FemCure). Treatment consisted of doxycycline (100 mg twice daily for 7 days) in rectal CT-positive women, and of azithromycin (1 g single dose) in vaginally positive women who were rectally untested or rectally negative. Participants self-collected rectal and vaginal samples at enrollment (treatment time-point) and during 4 weeks of follow-up. The endpoint was microbiological cure by a negative nucleic acid amplification test at 4 weeks. Differences between cure proportions and 95% confidence intervals (CIs) were calculated. RESULTS: We analyzed 416 patients, of whom 319 had both rectal and vaginal chlamydia at enrollment, 22 had rectal chlamydia only, and 75 had vaginal chlamydia only. In 341 rectal infections, microbiological cure in azithromycin-treated women was 78.5% (95% CI, 72.6%-83.7%; n = 164/209) and 95.5% (95% CI, 91.0%-98.2%; n = 126/132) in doxycycline-treated women (difference, 17.0% [95% CI, 9.6%-24.7%]; P < .001). In 394 vaginal infections, cure was 93.5% (95% CI, 90.1%-96.1%; n = 246/263) in azithromycin-treated women and 95.4% (95% CI, 90.9%-98.2%; n = 125/131) in doxycycline-treated women (difference, 1.9% [95% CI, -3.6% to 6.7%]; P = .504). CONCLUSIONS: The effectiveness of doxycycline is high and exceeds that of azithromycin for the treatment of rectal CT infections in women. CLINICAL TRIALS REGISTRATION: NCT02694497.
引用
- Dukers-Muijrers NHTM, Wolffs PFG, De Vries H, et al. Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure). Clin Infect Dis. 2019. PMID: 30689759. doi:10.1093/cid/ciz050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。